Cargando…

Moyamoya syndrome and neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargiami, Euthymia, Sapountzi, Evdoxia, Samakovitis, Dimitris, Batzios, Spyros, Kyriazi, Maria, Anastasiou, Athanasia, Zafeiriou, Dimitrios I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104827/
https://www.ncbi.nlm.nih.gov/pubmed/24952383
http://dx.doi.org/10.1186/1824-7288-40-59
_version_ 1782327291993391104
author Vargiami, Euthymia
Sapountzi, Evdoxia
Samakovitis, Dimitris
Batzios, Spyros
Kyriazi, Maria
Anastasiou, Athanasia
Zafeiriou, Dimitrios I
author_facet Vargiami, Euthymia
Sapountzi, Evdoxia
Samakovitis, Dimitris
Batzios, Spyros
Kyriazi, Maria
Anastasiou, Athanasia
Zafeiriou, Dimitrios I
author_sort Vargiami, Euthymia
collection PubMed
description Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that is only rarely observed in association with NF1, particularly in the pediatric age range. Herein, we report of a 5-year-old female with NF1 and moyamoya syndrome and we briefly review the existing literature.
format Online
Article
Text
id pubmed-4104827
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41048272014-07-22 Moyamoya syndrome and neurofibromatosis type 1 Vargiami, Euthymia Sapountzi, Evdoxia Samakovitis, Dimitris Batzios, Spyros Kyriazi, Maria Anastasiou, Athanasia Zafeiriou, Dimitrios I Ital J Pediatr Case Report Neurofibromatosis type 1 (NF1) is the most prevalent autosomal dominant genetic disorder among humans. NF1 vasculopathy is a significant but underrecognized complication of the disease, affecting both arterial and venous blood vessels of all sizes. Moyamoya syndrome is a cerebral vasculopathy that is only rarely observed in association with NF1, particularly in the pediatric age range. Herein, we report of a 5-year-old female with NF1 and moyamoya syndrome and we briefly review the existing literature. BioMed Central 2014-06-21 /pmc/articles/PMC4104827/ /pubmed/24952383 http://dx.doi.org/10.1186/1824-7288-40-59 Text en Copyright © 2014 Vargiami et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Vargiami, Euthymia
Sapountzi, Evdoxia
Samakovitis, Dimitris
Batzios, Spyros
Kyriazi, Maria
Anastasiou, Athanasia
Zafeiriou, Dimitrios I
Moyamoya syndrome and neurofibromatosis type 1
title Moyamoya syndrome and neurofibromatosis type 1
title_full Moyamoya syndrome and neurofibromatosis type 1
title_fullStr Moyamoya syndrome and neurofibromatosis type 1
title_full_unstemmed Moyamoya syndrome and neurofibromatosis type 1
title_short Moyamoya syndrome and neurofibromatosis type 1
title_sort moyamoya syndrome and neurofibromatosis type 1
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104827/
https://www.ncbi.nlm.nih.gov/pubmed/24952383
http://dx.doi.org/10.1186/1824-7288-40-59
work_keys_str_mv AT vargiamieuthymia moyamoyasyndromeandneurofibromatosistype1
AT sapountzievdoxia moyamoyasyndromeandneurofibromatosistype1
AT samakovitisdimitris moyamoyasyndromeandneurofibromatosistype1
AT batziosspyros moyamoyasyndromeandneurofibromatosistype1
AT kyriazimaria moyamoyasyndromeandneurofibromatosistype1
AT anastasiouathanasia moyamoyasyndromeandneurofibromatosistype1
AT zafeirioudimitriosi moyamoyasyndromeandneurofibromatosistype1